Literature DB >> 12965268

Qualitative evidence of anti-Yo-specific intrathecal antibody synthesis in patients with paraneoplastic cerebellar degeneration.

Oliver Stich1, Francesc Graus, Christiane Rasiah, Sebastian Rauer.   

Abstract

We investigated the presence of anti-Yo-specific oligoclonal antibody bands in cerebrospinal fluid (CSF) and serum samples of 9 patients with anti-Yo syndrome and 11 controls. Isoelectric focusing combined with affinity blotting, revealed anti-Yo-specific intrathecal antibody synthesis in all patients with anti-Yo syndrome: Four patients had positive anti-Yo-specific oligoclonal IgG bands in CSF which were not demonstrable in their sera; five CSF/serum pairs showed additional, more intensive, oligoclonal bands in CSF compared to the corresponding serum. Interestingly, four patients with absence of oligoclonal bands of total IgG in CSF revealed positive anti-Yo-specific oligoclonal bands in the same sample. This speaks for a higher sensitivity of detection of oligoclonal bands using an affinity blot loaded with Yo-specific antigen compared to an affinity blot coated with anti-human IgG used for the detection of oligoclonal bands of total IgG. In conclusion, the presence of anti-Yo-specific oligoclonal IgG bands in CSF which were absent, or less strong, in patients sera provides qualitative evidence of anti-Yo-specific IgG synthesis by intrathecal B-cell clones. These results could be of interest in detection of intrathecal-specific IgG synthesis in nervous system infectious diseases provided that the target antigen is known.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12965268     DOI: 10.1016/s0165-5728(03)00257-1

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  12 in total

1.  Qualitative evidence of anti-Ri specific intrathecal antibody synthesis and quantification of anti-Ri antibodies in serial samples from a patient with anti-Ri syndrome.

Authors:  O Stich; S Rauer
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-02       Impact factor: 10.154

Review 2.  The MRZ reaction as a highly specific marker of multiple sclerosis: re-evaluation and structured review of the literature.

Authors:  S Jarius; P Eichhorn; D Franciotta; H F Petereit; G Akman-Demir; M Wick; B Wildemann
Journal:  J Neurol       Date:  2016-12-22       Impact factor: 4.849

Review 3.  Brain-reactive antibodies and disease.

Authors:  B Diamond; G Honig; S Mader; L Brimberg; B T Volpe
Journal:  Annu Rev Immunol       Date:  2013       Impact factor: 28.527

Review 4.  [Paraneoplastic neurological syndromes and autoimmune encephalitis].

Authors:  O Stich; S Rauer
Journal:  Nervenarzt       Date:  2014-04       Impact factor: 1.214

5.  Cerebrospinal fluid findings in COVID-19: a multicenter study of 150 lumbar punctures in 127 patients.

Authors:  Martin Stangel; Klemens Ruprecht; Brigitte Wildemann; Sven Jarius; Florence Pache; Peter Körtvelyessy; Ilijas Jelčić; Mark Stettner; Diego Franciotta; Emanuela Keller; Bernhard Neumann; Marius Ringelstein; Makbule Senel; Axel Regeniter; Rea Kalantzis; Jan F Willms; Achim Berthele; Markus Busch; Marco Capobianco; Amanda Eisele; Ina Reichen; Rick Dersch; Sebastian Rauer; Katharina Sandner; Ilya Ayzenberg; Catharina C Gross; Harald Hegen; Michael Khalil; Ingo Kleiter; Thorsten Lenhard; Jürgen Haas; Orhan Aktas; Klemens Angstwurm; Christoph Kleinschnitz; Jan Lewerenz; Hayrettin Tumani; Friedemann Paul
Journal:  J Neuroinflammation       Date:  2022-01-20       Impact factor: 8.322

6.  Usefulness of antibody index assessment in cerebrospinal fluid from patients negative for total-IgG oligoclonal bands.

Authors:  Sven Jarius; Peter Eichhorn; Brigitte Wildemann; Manfred Wick
Journal:  Fluids Barriers CNS       Date:  2012-07-31

Review 7.  'Medusa-head ataxia': the expanding spectrum of Purkinje cell antibodies in autoimmune cerebellar ataxia. Part 1: Anti-mGluR1, anti-Homer-3, anti-Sj/ITPR1 and anti-CARP VIII.

Authors:  S Jarius; B Wildemann
Journal:  J Neuroinflammation       Date:  2015-09-17       Impact factor: 8.322

Review 8.  'Medusa head ataxia': the expanding spectrum of Purkinje cell antibodies in autoimmune cerebellar ataxia. Part 3: Anti-Yo/CDR2, anti-Nb/AP3B2, PCA-2, anti-Tr/DNER, other antibodies, diagnostic pitfalls, summary and outlook.

Authors:  S Jarius; B Wildemann
Journal:  J Neuroinflammation       Date:  2015-09-17       Impact factor: 8.322

Review 9.  Intrathecal IgG synthesis: a resistant and valuable target for future multiple sclerosis treatments.

Authors:  Mickael Bonnan
Journal:  Mult Scler Int       Date:  2015-01-08

Review 10.  Paraneoplastic neurological syndromes.

Authors:  Jérôme Honnorat; Jean-Christophe Antoine
Journal:  Orphanet J Rare Dis       Date:  2007-05-04       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.